Handling Uncertainty in Health Technology Assessment Processes
Author(s)
Faculty: Natalia Kunst, PhD, Centre for Health Economics, University of York, York, UK Lotte Steuten, PhD, Office of Health Economics, London, UK; Elisabeth Anne Louise Fenwick, PhD, OPEN Health Evidence & Access, Oxford, UK
Separate registration required.
Due to scarce resources, decisions must be made regarding which interventions to reimburse in the healthcare sector. In many countries, model-based economic evaluations are used as part of the Health Technology Assessment (HTA) process to systematically assess the magnitude and tradeoffs of the expected health effects and costs of decision options considered. Such assessment is based on incomplete information, often resulting in uncertainty, which in the extreme can result in suboptimal decision making. Consequently, an economic evaluation for HTA purposes should be performed using a coherent framework to properly structure the decision-making process and should carefully assess the uncertainty surrounding the expected outcomes and the decision being addressed. This course will provide participants with 1) a taxonomy of the types of uncertainty that should be considered when preparing and assessing economic evaluations for HTA purposes; 2) a more in-depth understanding of different methods to appropriately assess the underlying uncertainty and make more informed decisions based on economic evaluations; and 3) guidance on how to report uncertainty using the latest ISPOR good-practice guidelines. Further, the participants will practice with several of these methods and interpretation of their results in hands-on exercises.
PREREQUISITE: This course requires familiarity with basic economic evaluation and HTA concepts and methodologies.
Conference/Value in Health Info
2024-05, ISPOR 2024, Atlanta, GA, USA
Code
009
Topic
Health Technology Assessment